在治疗严重喘时,生物启动的持续时间和决定因素
Tatsuya Imabayashi1, Toshiyuki Tanaka1, Kohei Yamamoto1
1Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, 15-749, Honmachi, Higashiyama-ku, Kyoto, 605-0981, Japan.
Respiratory investigation
|June 7, 2025
概括
开始治疗严重喘的生物药物的延迟与频繁的恶化和没有行动计划的口服皮质类固醇 (OCS) 常规使用有关. 避免习惯性使用OCS可以帮助加快生物治疗.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物疗法为严重喘提供了新的治疗途径.
- 了解延迟生物启动的因素对于优化患者护理至关重要.
研究的目的:
- 研究严重喘患者生物发病的持续时间和决定因素.
- 确定导致生物治疗开始延迟的因素.
主要方法:
- 54名在2018年至2024年期间开始使用生物药物的严重喘患者的回顾性评估.
- 分析患者的人口统计,治疗前的特征和生物启动的原因.
主要成果:
- 患者对生物启动需要平均三种解释,超过25%需要四种或更多.
- 预先处方的口服皮质类固醇 (OCS) 用于预期的恶化和更频繁的恶化与需要更多解释有关.
- 预先处方的OCS是需要多个解释的一个独立因素 (aOR,10.50;P = .008).
- 恶化是启动生物药物的主要决定因素 (64.8%).
结论:
- 没有明确的行动计划的习惯性预先处方口服皮质类固醇 (OCS) 使用有助于延迟生物启动.
- 频繁的恶化也在延迟及时获得生物疗法的过程中发挥作用.
- 需要采取避免在没有行动计划的情况下常规使用OCS的策略,以促进迅速的生物启动.
相关概念视频
Asthma: Pathogenesis and Management
623
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
623
Antiasthma Drugs: β2-Adrenoceptor Agonists
407
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
407
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
COPD: Management Using Bronchodilators and Corticosteroids
331
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
331


